Balance Sheet

v3.20.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 11 $ 433
Accounts receivable 6 28
Inventories 157 123
Prepaid expenses 7
Total current assets 174 591
Equipment, net 232 313
Operating lease right-of-use asset, net 383 333
Deposits 17 34
Total assets 806 1,271
Current liabilities:    
Accounts payable and accrued expenses 460 74
Notes payable (net of discount of $25 and deferred finance charges of $89 at September 30, 2020) 420 56
Convertible note payable (net of premium of $125 and $0 and discount of $497 and $255, respectively) 600 57
Deferred revenue, license agreement 43 33
Operating lease liabilities, short-term 99 86
Settlement Reserve 236
Derivative liabilities 400
Total current liabilities 1,858 706
Long term liabilities    
Deferred revenue, licenses agreement, long-term 34
Notes payable, long term 483
Operating lease liabilities, long-term 315 252
Total liabilities 2,656 992
Stockholders' equity (deficit):    
Preferred stock, $0.001 par value; 25,000,000 shares authorized; 2,500,000 issued and outstanding 2
Common stock, $0.001 par value; 100,000,000 shares authorized; 60,779,130 and 49,087,255 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 62 49
Shares to be issued (4,250,000 and 7,318,519 as of September 30, 2020 and December 31, 2019, respectively) 3,320 2,848
Additional paid-in capital 8,935 5,620
Accumulated deficit (14,169) (8,238)
Total stockholders' equity (deficit) (1,850) 279
Total liabilities and stockholders' equity (deficit) $ 806 $ 1,271

Source